Nictur (Desmopressin)

Desmopressin mimics the natural hormone vasopressin and binds to V2 receptors in the kidney collecting ducts. This triggers a cascade that increases cyclic AMP, causing aquaporin‑2 channels to move to the cell surface, which allows more water to be reabsorbed and concentrates the urine.

The appropriate dose of Nictur is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function and response to therapy. Dosage regimens are not standardized in public information and must follow the prescriber’s instructions.

The pregnancy and lactation categories for Nictur are not definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss use with a qualified obstetrician or pediatrician before prescribing to pregnant or nursing individuals.

To request Nictur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Nictur contains desmopressin, a selective V2‑receptor agonist, offering a longer half‑life and fewer vasoconstrictive effects than natural vasopressin. Compared with other antidiuretics, it provides more predictable water‑reabsorption and is the preferred choice for central diabetes insipidus and bleeding disorders due to its hemostatic activity.

Nictur should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and avoid storing it in areas with high humidity or temperature fluctuations.

Nictur is taken orally. The tablet (or oral formulation) should be swallowed whole with water, unless the prescribing information advises otherwise. It is usually taken at the same times each day to maintain consistent plasma levels.

The most critical safety concerns are severe hyponatremia and water intoxication, which can lead to seizures, coma or death. Patients should be monitored for rapid weight gain, confusion, headache or nausea, and serum sodium should be checked regularly, especially during the initial treatment phase.

Nictur is contraindicated in individuals with known hypersensitivity to desmopressin, uncontrolled hyponatremia, severe renal impairment, or conditions predisposing to water retention such as congestive heart failure. Clinicians should also avoid use in patients taking interacting medications that markedly increase the risk of hyponatremia.